Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SORAFENIB Cause Peripheral arterial occlusive disease? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Peripheral arterial occlusive disease have been filed in association with SORAFENIB (sorafenib). This represents 0.1% of all adverse event reports for SORAFENIB.

9
Reports of Peripheral arterial occlusive disease with SORAFENIB
0.1%
of all SORAFENIB reports
1
Deaths
6
Hospitalizations

How Dangerous Is Peripheral arterial occlusive disease From SORAFENIB?

Of the 9 reports, 1 (11.1%) resulted in death, 6 (66.7%) required hospitalization, and 2 (22.2%) were considered life-threatening.

Is Peripheral arterial occlusive disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does SORAFENIB Cause?

Hepatocellular carcinoma (1,665) Diarrhoea (1,611) Off label use (1,587) Fatigue (1,041) Palmar-plantar erythrodysaesthesia syndrome (1,040) Decreased appetite (906) Death (904) Asthenia (777) Nausea (716) Rash (613)

What Other Drugs Cause Peripheral arterial occlusive disease?

NILOTINIB (319) METHOTREXATE (120) ADALIMUMAB (116) RIVAROXABAN (101) PONATINIB (90) IMATINIB (86) ASPIRIN (77) ATORVASTATIN (70) METOPROLOL (70) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)

Which SORAFENIB Alternatives Have Lower Peripheral arterial occlusive disease Risk?

SORAFENIB vs SORGHUM HALEPENSE POLLEN SORAFENIB vs SOTAGLIFLOZIN SORAFENIB vs SOTALOL SORAFENIB vs SOTATERCEPT SORAFENIB vs SOTATERCEPT-CSRK

Related Pages

SORAFENIB Full Profile All Peripheral arterial occlusive disease Reports All Drugs Causing Peripheral arterial occlusive disease SORAFENIB Demographics